Liaci Enrico, Negri Maurizio, Maccarrone Francesco, Piccinini Silvia, Pasanisi Enrico, Bacciu Andrea, Di Lella Filippo
The Department of Medicine and Surgery, University of Parma, Parma, Italy.
Department of Otolaryngology and Otoneurosurgery, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy.
J Int Adv Otol. 2024 Nov 25;20(6):484-488. doi: 10.5152/iao.2024.241645.
Intracochlear schwannomas (ICSs) are a subtype of intralabyrinthine schwannomas, completely located in the cochlear lumen. ICSs are particularly rare in the pediatric population. Putative diagnosis is made on the basis of magnetic resonance findings with signal characteristics that should remain the same at follow-up imaging.
A retrospective review was performed searching for pediatric patients affected by ICS treated at the Otolaryngology Department, Ospedale Ramazzini, Carpi (Italy), and Otolaryngology and Otoneurosurgery Department, Azienda Ospedaliero-Universitaria di Parma, (Italy). A scoping literature review of the period January 2000 - June 2024 was performed.
Two cases of ICS in pediatric patients are described. Neither family history nor genetic signs of neurofibromatosis type II were found. A single report was identified in the literature review. Data analysis resumes the pooled data of the latter case and the authors' patients. The most common symptom at presentation was progressive sensorineural hearing loss (66%). Mean pure tone average at diagnosis was 74.2 dB. Intracochlear location was in the basal turn in 2 cases and in the apical and middle turns in the third patient. All cases initially underwent a "wait and scan" strategy. The mean follow-up time was 23.3 months.
Management planning of pediatric ICSs should be accurate as surgical removal may require partial or total cochlear demolition, resulting in vestibular dysfunction and precluding future positioning of a cochlear implant. Close clinical and radiological follow-up with serial MRI scans allows to evaluate both symptom progression and rate of growth, in order to provide patients with the best therapeutic option.
耳蜗内神经鞘瘤(ICSs)是迷路内神经鞘瘤的一种亚型,完全位于耳蜗腔内。ICSs在儿科人群中尤为罕见。基于磁共振成像结果进行初步诊断,其信号特征在后续成像中应保持不变。
对意大利卡尔皮拉马齐尼医院耳鼻喉科以及意大利帕尔马大学医院耳鼻喉科和耳神经外科治疗的患有ICS的儿科患者进行回顾性研究。对2000年1月至2024年6月期间的文献进行了范围综述。
描述了2例儿科患者的ICS病例。未发现家族病史或II型神经纤维瘤病的遗传迹象。在文献综述中确定了一份单一报告。数据分析汇总了后一病例和作者患者的合并数据。就诊时最常见的症状是进行性感音神经性听力损失(66%)。诊断时的平均纯音平均值为74.2 dB。2例耳蜗内位置在基底转,第3例患者在顶转和中转。所有病例最初均采用“等待观察并扫描”策略。平均随访时间为23.3个月。
儿科ICS的管理规划应准确,因为手术切除可能需要部分或全部拆除耳蜗,导致前庭功能障碍并排除未来植入人工耳蜗的可能性。通过连续MRI扫描进行密切的临床和影像学随访,可以评估症状进展和生长速度,以便为患者提供最佳治疗选择。